Adam Hanina

Adam Hanina is CEO/Founder of Dandelion Science, pioneering computational precision therapies for vision and brain disorders. He has founded multiple AI healthcare ventures, achieved eight-figure revenues, raised $66.9M including US and Swiss government grant funding, and holds 52 patents in neurotechnology, AI monitoring, and analytics. Honored in PharmaVOICE 100, he has spoken at CES, WHO, BIO, DIA, Wharton, and MIT. He holds an MBA from Wharton, an MPhil from Cambridge, and a BA from Brown.